Pneumococcal conjugate second or third-dose vaccines (PCVc) in Lower-middle income (World Bank)
Lower-middle income (World Bank): Pneumococcal conjugate second or third-dose vaccines (PCVc) was 81.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Lower-middle income (World Bank), 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Lower-middle income (World Bank) is 81.0%, measured in 2025. That is the highest value across all 18 years on record.
Compared with earlier readings it is up 161.3% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Lower-middle income (World Bank) peaked at 81.0% in 2024 and was at its lowest, 0.0%, in 2008.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Lower-middle income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 3.0% | — |
| 2012 | 6.0% | +100.0% |
| 2013 | 17.0% | +183.3% |
| 2014 | 21.0% | +23.5% |
| 2015 | 31.0% | +47.6% |
| 2016 | 36.0% | +16.1% |
| 2017 | 41.0% | +13.9% |
| 2018 | 45.0% | +9.8% |
| 2019 | 49.0% | +8.9% |
| 2020 | 51.0% | +4.1% |
| 2021 | 51.0% | +0.0% |
| 2022 | 68.0% | +33.3% |
| 2023 | 76.0% | +11.8% |
| 2024 | 81.0% | +6.6% |
| 2025 | 81.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 24.9% | 0.0% | 49.0% | 10 |
| 2020s | 68.0% | 51.0% | 81.0% | 6 |
Countries ranked near Lower-middle income (World Bank)
- 1 Cook Islands 99.0% compare
- 1 Hungary 99.0% compare
- 1 Oman 99.0% compare
- 1 Bahrain 99.0% compare
- 1 Seychelles 99.0% compare
- 1 Bhutan 99.0% compare
- 1 Cuba 99.0% compare
- 1 Palestine, State of 99.0% compare
- 1 Uzbekistan 99.0% compare
- 1 Guyana 99.0% compare
More health data for Lower-middle income (World Bank)
- Pertussis - number of reported cases 7,080 (2025)
- Diphtheria - number of reported cases 20,601 (2025)
- Measles - number of reported cases 97,321 (2025)
- Total tetanus - number of reported cases 16,092 (2025)
- Neonatal tetanus - number of reported cases 838 (2025)
- Infant mortality rate (probability of dying between birth and age 1) 33.08 (2024)
- Number of neonatal deaths 1.39 million (2024)
- Thinness among children and adolescents, BMI-for-age < -2 standard 13.5% (2024)
- Under-five mortality rate 43.8 (2024)
- Neonatal mortality rate 21.61 (2024)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Lower-middle income (World Bank)?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Lower-middle income (World Bank) was 81.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Lower-middle income (World Bank)?
- The highest recorded value was 81.0% in 2024.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Lower-middle income (World Bank)?
- The lowest recorded value was 0.0% in 2008.
- How does Lower-middle income (World Bank) rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Lower-middle income (World Bank) ranks 4th out of 11 groups with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Lower-middle income (World Bank)?
- Over the last ten years it is up 161.3%. The long-run trend across the full record is volatile.
- Where does this Lower-middle income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).